Altium Capital Management

06/10/2022

Altium Capital in proud to introduce Altium Cares!
Learn more at altiumcares.org

06/08/2022

Introducing Altium Cares!

Learn more at: www.altiumcares.org

10/11/2021

These are the Top Impact Investment Companies in New York (2021)- featuring Altium Capital
https://lnkd.in/dxVcFFQg

09/15/2021

https://lnkd.in/d5CtaCKu

"A group of premier investors participated in the PIPE financing, including RTW Investments LP, Surveyor Capital (a Citadel company), Chardan Healthcare Investments, Acorn Bioventures, Innogest Capital and Longview Ventures (an affiliate of Broadview Ventures). Other top-tier investors participating in the business combination include 683 Capital, Affinity Asset Advisors, Altium Capital, Ikarian Capital, Sio Capital Management and South Ocean Capital Management"

Chardan Healthcare Acquisition 2 Corp. , a special purpose acquisition company sponsored by Chardan Capital Markets (

03/29/2021

Top deals in US medical devices industry venture financing deals in February 2021: GlobalData

03/25/2021

https://www.streetinsider.com/Globe+Newswire/Cellect+Biotechnology+and+Quoin+Pharmaceuticals+Announce+Strategic+Merger/18172996.html

Up to $25 million of funding at $75 million pre-money valuation to be available to the combined company concurrently with the merger  Cellect shareholders to retain 25% of the...

03/25/2021

Medical Devices industry top five cross border deals globally in February 2021, according to GlobalData.

03/08/2021

"The financing from leading healthcare investors included Farallon Capital Management, Polaris Partners, HBM Healthcare Investments, Altium Capital Management.."

Proceeds will advance two lead xenotransplantation programs in kidney failure and type 1 diabetes into first-in-human studies

02/24/2021

Altium Capital and Sio Capital recently formed Medicus Sciences Acquisition Corp., a $92 million S**C publicly traded on the Nasdaq under the symbol, MSACU, for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. While Medicus may acquire a company in any industry, its focus is on the healthcare industry, particularly the medical technology sector. In addition, Altium and Sio have entered into forward purchase agreements to invest up to $16 million in connection with an initial business combination with Medicus.

Medicus Sciences Acquisition Corp. (“MSAC”) is a blank check company formed for the purpose of effecting merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While MSAC may pursue an initial business combination op...

02/01/2021

A single shot of a coronavirus vaccine developed by Johnson & Johnson protected volunteers enrolled in a sprawling, multi-country study from developing COVID-19

The vaccine's efficacy was higher in the U.S., but lower in Latin America and South Africa, where new, more infectious virus variants are circulating. 

01/25/2021

Merck & Co. will stop developing two experimental coronavirus vaccines after both produced disappointing results in early-stage testing.

The drugmaker, one of the largest vaccine developers, won't move forward with two candidates it's been testing after disappointing data in early trials.

01/20/2021

After a record year for biotech IPOs in 2020, forecasts were bullish on another strong year showing for public offerings — and 2021 hasn’t disappointed so far.

After a record year for biotech IPOs in 2020, forecasts were bullish on another strong year showing for public offerings — and 2021 hasn't disappointed so far. Now, a clutch of four biotechs chasing rare disease and cancer and a New York S**C are ready to join the party. Three